secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2022-01-12T23:59:59+00:00
Accession:  0001104659-22-003432
Event type: leadership
Sentiment:  negative
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hepion Pharmaceuticals announces death of director Thomas Adams
---------------------------------------------------------------

- Thomas Adams, Ph.D., passed away on January 9, 2022 due to natural causes.
- Dr. Adams served on Hepion's board since September 2016.
- No replacement director has been announced as of the press release date.
- Company expressed condolences; no other operational changes reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000110465922003432/0001104659-22-003432-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000110465922003432/tm222713d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-003432

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer